Covestro, der MDax-König 2016

Das kann sich sehen lassen: 90 Prozent Plus gehen auf das 2016er Konto der Covestro-Aktie. Kann das 2017 für den Bayer-Ableger …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
570